-
Je něco špatně v tomto záznamu ?
Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT
R. Lohynska, M. Jirkovska, B. Malinova, A. Novakova-Jiresova, Z. Pechacova, Z. Kratka
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
34498610
DOI
10.5507/bp.2021.047
Knihovny.cz E-zdroje
- MeSH
- celková dávka radioterapie MeSH
- lidé MeSH
- nádory hlavy a krku * radioterapie MeSH
- prognóza MeSH
- radioterapie s modulovanou intenzitou * MeSH
- retrospektivní studie MeSH
- tumor burden MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: The relationship of tumour volume, radiotherapy treatment time and other prognostic factors affecting prognosis was evaluated. METHODS: 184 patients with locally advanced head and neck cancer were treated with radical intensity modulated radiotherapy (IMRT) and compared retrospectively. RESULTS: In the multivariate analysis the overall survival was dependent on gross tumour volume (GTV), clinical stage (CS), radiotherapy treatment time (RTT) and p16 status. Local control was influenced by GTV, overall RTT and age. DFS was significantly affected by GTV, CS, RTT, p16 status and concomitant chemotherapy (CHT). CONCLUSIONS: The tumour volume and the radiotherapy treatment time were the most significant prognostic factors with the best outcomes in patients with GTV ≤ 55 cc and RTT ≤ 48 days (mean LC 8.1, DFS 7.1 and OS 6.4 years) and worst outcomes with GTV > 55 cc and RTT >48 days (mean LC 4.4, mean DFS 3.2 and mean OS 2.6 years).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22029537
- 003
- CZ-PrNML
- 005
- 20230118155254.0
- 007
- ta
- 008
- 230113s2022 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2021.047 $2 doi
- 035 __
- $a (PubMed)34498610
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Lohynská, Radka $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $7 xx0233443
- 245 10
- $a Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT / $c R. Lohynska, M. Jirkovska, B. Malinova, A. Novakova-Jiresova, Z. Pechacova, Z. Kratka
- 520 9_
- $a AIMS: The relationship of tumour volume, radiotherapy treatment time and other prognostic factors affecting prognosis was evaluated. METHODS: 184 patients with locally advanced head and neck cancer were treated with radical intensity modulated radiotherapy (IMRT) and compared retrospectively. RESULTS: In the multivariate analysis the overall survival was dependent on gross tumour volume (GTV), clinical stage (CS), radiotherapy treatment time (RTT) and p16 status. Local control was influenced by GTV, overall RTT and age. DFS was significantly affected by GTV, CS, RTT, p16 status and concomitant chemotherapy (CHT). CONCLUSIONS: The tumour volume and the radiotherapy treatment time were the most significant prognostic factors with the best outcomes in patients with GTV ≤ 55 cc and RTT ≤ 48 days (mean LC 8.1, DFS 7.1 and OS 6.4 years) and worst outcomes with GTV > 55 cc and RTT >48 days (mean LC 4.4, mean DFS 3.2 and mean OS 2.6 years).
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a radioterapie s modulovanou intenzitou $7 D050397
- 650 _2
- $a tumor burden $7 D047368
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a nádory hlavy a krku $x radioterapie $7 D006258
- 650 _2
- $a celková dávka radioterapie $7 D011879
- 650 _2
- $a prognóza $7 D011379
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jirkovská, Michaela $u Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $7 xx0249094
- 700 1_
- $a Malinová, Běla $u Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic $7 xx0158456
- 700 1_
- $a Nováková-Jirešová, Alena $u Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic $7 xx0266859
- 700 1_
- $a Pechačová, Zdeňka $u Institute of Radiation Oncology, First Faculty of Medicine, Charles University and Bulovka University Hospital, Prague, Czech Republic $7 xx0168238
- 700 1_
- $a Krátká, Zuzana $u Department of Otorhinolaryngology, Thomayer University Hospital Prague, Czech Republic $7 xx0249120
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1804-7521 $g Roč. 166, č. 4 (2022), s. 405-411
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34498610 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20230113 $b ABA008
- 991 __
- $a 20230118155249 $b ABA008
- 999 __
- $a ok $b bmc $g 1885633 $s 1180862
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 166 $c 4 $d 405-411 $e 20210824 $i 1804-7521 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK138 $a Pubmed-20230113